TY  - GEN
AU  - Yeung,D T
AU  - Moulton,D J
AU  - Heatley,S L
AU  - Nievergall,E
AU  - Dang,P
AU  - Braley,J
AU  - Branford,S
AU  - Moore,S
AU  - Mullighan,C G
AU  - Hughes,T P
AU  - White,D L
TI  - Relapse of BCR-ABL1-like ALL mediated by the ABL1 kinase domain mutation T315I following initial response to dasatinib treatment
SN  - 1476-5551
PY  - 2015///0324
KW  - Dasatinib
KW  - Fusion Proteins, bcr-abl
KW  - genetics
KW  - Humans
KW  - Mutation
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - drug therapy
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - Protein Kinases
KW  - Pyrimidines
KW  - Recurrence
KW  - Thiazoles
N1  - Publication Type: Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2014.256
ER  -